ODI Pharma

3.88 SEK

-0.51 %

Less than 1K followers

ODI

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

-0.51 %
+2.11 %
+11.49 %
-10.19 %
+280.39 %
+113.19 %
-18.68 %
-20.51 %
-65.45 %

ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are made through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. Operations are found within the European market, with the headquarters in Stockholm.

Read more
Market cap
71.12M SEK
Turnover
2.68K SEK
Revenue
3.11M
EBIT %
-168.49 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28/5
2026

Interim report Q3'26

27/8
2026

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.